BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » 2016 on Track for a 20% Increase in Mesenchymal Stem Cell (MSC) Publications
2016 on Track for a 20% Increase in Mesenchymal Stem Cell (MSC) Publications

2016 on Track for a 20% Increase in Mesenchymal Stem Cell (MSC) Publications

July 20, 2016 By Cade Hildreth (CEO) Leave a Comment

Recently, we released an article stating that two-thirds of mesenchymal stem cell (MSC) scientific publications were released in the past 5 years, even though there is a 40 year history of MSC publications.

Discover class-defining bioproduction tools.

What is even more shocking is that more than a quarter (27.4%) of all MSC publications were released during 2014 or 2015, the previous two years.

Moreover, 2016 data shows that we are on track for a nearly 20% increase in MSC publications over 2015. 

At BioInformant, we have been tracking the mesenchymal stem cell market for a full decade (2006 to present) and we have never seen MSC scientific publication data look like this.

Rooster DevServices

In market research, we are at what we call an “Inflection Point.” Meaning, we are at a time of significant change in a situation, a turning point.

Whether you manufacture stem cell products, develop stem cell therapies, or offer cord blood banking services, you need to be aware of trends like this.

bitbio

Explore our blog for more free content on mesenchymal stem cell (MSC) market trends or check out the global strategic report “Mesenchymal Stem Cells – Advances & Applications.”

*Note: PubMed search of terms “mesenchymal stem cell” and “mesenchymal stem cells” executed July 15, 2016.

Pluristyx

About BioInformant

BioInformant is the first and only market research firm to specialize in the stem cell industry. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, Vogue Magazine, and more. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.

Rate this post

Filed Under: MSCs, Stem Cells Tagged With: MSC, scientific publications, trends

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Tell Us What You Think! Cancel reply

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Featured Posts

Who discovered stem cells?

Who Discovered Stem Cells? The Answers Revealed

iPSC derived cell therapeutics

The Pipeline for iPSC-Derived Cell Therapeutics in 2022

Stem cell companies

List of Stem Cell Companies Worldwide (2022)

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.